Enríquez-Labrada RD, Delgado-Espín R, Serrano-Bello CA, Sánchez-Curiel-Loyo M

Language: Spanish
References: 8
Page: 140-145
PDF size: 607.94 Kb.

ABSTRACT

We present the images, both magnetic resonance, computed tomography and gammagraphy obtained during the evolution of a 13-year-old patient with osteosarcoma that developed pulmonary metastases. These images are from diagnosis, treatment and when metastases were detected. Histopathological findings are also described.

REFERENCES

1. National Comprehensive Cancer Network. Bone Cancer (Version 2.2017). Accessed June 6, 2017. Available in: https://www.nccn.org/professionals/physician_gls/PDF/bone.pdf.

2. The ESMO/European Sarcoma Network Working Group; Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2012; 23 (Suppl. 7): vii100-vii109, https://doi.org/10.1093/annonc/mds254.

3. Durfee RA, Mohammed M, Luu HH. Review of osteosarcoma and current management. Rheumatol Ther. 2016; 3: 221-243.

4. Chen F, Miyahara R, Bando T, Okubo K, Watanabe K, Nakayama T et al. Prognostic factors of pulmonary metastasectomy for osteosarcomas of the extremities. Eur J Cardiothorac Surg. 2008; 34: 1235-1239.

5. Goto Y, Ihara K, Kawauchi S, Ohi R, Sasaki K, Kawai S. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors. J Orthop Sci. 2002; 7(3): 304-312. doi: 10.1007/s007760200052.

6. Harrison DJ, Parisi MT, Shulkin BL. The Role of 18F-FDG-PET/CT in pediatric sarcoma. Semin Nucl Med. 2017; 47(3): 229-241.

7. Uslu L, Donig J, Link M, Rosenberg J, Quon A, Daldrup-Link HE. Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies. J Nucl Med. 2015; 56(2): 274-286.

8. Hongtao L, Hui Z, Bingshun W, Xiaojin W, Zhiyu W, Shuier Z et al. 18F-FDG positron emission tomography for the assessment of histological response to neoadjuvant chemotherapy in osteosarcomas: a meta-analysis. Surg Oncol. 2012; 21(4): e165-e170. doi: 10.1016/j.suronc.2012.07.002.